StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / chimeron.com

Chimeron Bio

Chimeron Bio (chimeron.com): 4 changes recorded in its website history since July 2017.

The website did not answer the latest live check. Last tried 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeHarnessing Genetic Medicine & saRNA to Transform Oncology
    AfterPioneering MultiPlex In-Vivo CAR-T Therapy

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. MessagingBetween and
    BeforeFuture Forward.
    AfterHarnessing Genetic Medicine & saRNA to Transform Oncology

    Classifier interpretation of website text.

    earlier archived pagelater archived pageLink to observation
  3. HeadlineBetween and
    BeforeCombining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.
    AfterFuture Forward.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  4. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 10 July 2017

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

Chimeron Bio is committed to discovering and developing personalized immunotherapeutics that will revolutionize the treatment of cancer.

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. January 2026 – June 2026 · 2 captures · latest observed messagingPioneering MultiPlex In-Vivo CAR-T Therapy

    Pioneering MultiPlex In-Vivo CAR-T Therapy A new wave in genetic medicine – multiplexed, precise, and delivered at scale. DISCOVER OUR APPROACH Breakthrough Science MultiPlex genetic engineering previ

    This wording observed 9 June 2026.

    archived page
    Inspect 2 captures in this group
    • 20 January 2026 · Pioneering MultiPlex In-Vivo CAR-T Therapy archived page
    • 9 June 2026 · Pioneering MultiPlex In-Vivo CAR-T Therapy archived page
  2. January 2025 – July 2025 · 2 capturesHarnessing Genetic Medicine & saRNA to Transform Oncology

    Harnessing Genetic Medicine & saRNA to Transform Oncology Developing in vivo CAR, immuno-oncology, and cancer vaccine therapeutics. OUR UNIQUE APPROACH Our Mission We’re dedicated to advancing genetic

    This wording observed 26 July 2025.

    archived page
    Inspect 2 captures in this group
    • 10 January 2025 · Harnessing Genetic Medicine & saRNA to Transform Oncology archived page
    • 26 July 2025 · Harnessing Genetic Medicine & saRNA to Transform Oncology archived page
  3. Seen January 2024 · 1 captureFuture Forward.

    Future Forward. Next generation RNA technology. OUR UNIQUE APPROACH Our Vision Chimeron Bio is redefining genetic medicine with future-forward RNA technology designed to deliver meaningful results for

    This wording observed 4 January 2024.

    archived page
  4. January 2021 – February 2023 · 3 capturesCombining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.

    Chimeron Bio is combining a first-in-class platform & the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics.

    This wording observed 1 February 2023.

    archived page
    Inspect 3 captures in this group
    • 18 January 2021 · Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy. archived page
    • 17 January 2022 · Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy. archived page
    • 1 February 2023 · Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy. archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Chimeron Bio now highlights multiplex in‑vivo CAR‑T therapy

Chimeron Bio’s website messaging has shifted from broad RNA therapy and synthetic genomics to a focus on multiplex in‑vivo CAR‑T therapy, with intermediate emphasis on genetic medicine and saRNA, and the company has also introduced a careers page.

  • Between July 2025 and January 2026, Chimeron Bio changed its homepage headline to “Pioneering MultiPlex In-Vivo CAR-T Therapy”. [4]
  • Between January 2024 and January 2025, a classifier read Chimeron Bio’s homepage change to “Harnessing Genetic Medicine & saRNA to Transform Oncology” as a repositioning. [3]
  • Between February 2023 and January 2024, Chimeron Bio changed its homepage headline from “Combining our first-in-class platform & the science of synthetic genomics to transform RNA therapy.” to “Future Forward.” [2]
  • Between August 2019 and January 2021, Chimeron Bio added a careers page to its website. [1]

Cite this record

StartupHistory, “Chimeron Bio” company record, https://startuphistory.org/c/chimeron.com

Machine-readable: /c/chimeron.com.json. How changes are found: method.